{"id":31967,"date":"2024-05-06T09:30:14","date_gmt":"2024-05-06T13:30:14","guid":{"rendered":"https:\/\/avalere.com\/?p=31967"},"modified":"2024-05-06T15:46:58","modified_gmt":"2024-05-06T19:46:58","slug":"adult-seasonal-combination-respiratory-vaccines-policy-considerations","status":"publish","type":"post","link":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations","title":{"rendered":"Adult Seasonal Combination Respiratory Vaccines: Policy Considerations"},"content":{"rendered":"

Combination vaccines can provide protection against and potentially prevent multiple diseases through a single vaccination. Multiple adult combination vaccines are emerging in development pipelines and are expected to launch in the next decade, including products that confer protection against several respiratory illnesses such as influenza, COVID-19, and respiratory syncytial virus (RSV). Stakeholders have noted the potential benefits of adult combination vaccines, citing several advantages documented in the childhood market<\/a> which has a variety of existing combination products. These benefits include improved vaccine coverage rates, timely vaccination for under vaccinated individuals, decreased shipping\/stocking costs, and reduced costs associated with extra healthcare visits.<\/p>\n

As stakeholders prepare for the launch of combination vaccines, they must consider key questions surrounding product approval, recommendation development, coverage, and reimbursement pathways. In a white paper, Avalere discussed these questions and identified the below issues and considerations:<\/p>\n

Table 1. Summary of Access Considerations for Combination Influenza-COVID-19 Vaccines and Key Stakeholders<\/h2>\n\n\n\n\n\n\n\n\n
Issue Area<\/th>\nConsiderations<\/th>\n\u00a0Key Stakeholders<\/th>\n<\/tr>\n<\/thead>\n
Strain Selection Timeline<\/td>\n\u2022 Stakeholders will need to consider how to approach strain selection for combination vaccines, as current influenza and COVID-19 processes vary
\n\u2022 Balancing strain selection timeliness with precision may be more consequential for combination vaccines due to differences in disease patterns and seasonal debut
\n\u2022 Stakeholders may explore streamlined approaches, e.g., a single review timeline based on vaccine type or platform<\/td>\n		\u2022 WHO, TAG-CO-VAC
\n\u2022 FDA, VRBPAC<\/td>\n<\/tr>\n
ACIP Review<\/td>\n\u2022 ACIP will need to decide whether to form a new Adult Combination Vaccine WG or rely on existing WGs
\n\u2022 If relying on existing WGs, ACIP may need to establish new approaches to working and collaboration when two or more WGs are reviewing the same combination product
\n\u2022 ACIP and other stakeholders will also need to consider recommendation timing; a later recommendation for either component could impact payer coverage and patient access<\/td>\n		\u2022 CDC, ACIP<\/td>\n<\/tr>\n
Product Coverage and Reimbursement<\/td>\n\u2022 Clarity is needed to understand if influenza\/COVID-19 combination vaccine coverage will be limited to a certain window\/season
\n\u2022 While Part B coverage is likely, CMS may need to clarify when product payment is anticipated
\n\u2022 CMS\u2019s Center for Consumer Information and Insurance Oversight (CCIIO) may need to clarify whether commercial market coverage timelines for COVID-19 vaccines applies to combination products
\n\u2022 CDC and other stakeholders may need to assess strategies to provide access for uninsured adults<\/td>\n		\u2022 Commercial insurers
\n\u2022 CMS
\n\u2022 CCIIO
\n\u2022 Medicaid agencies
\n\u2022 Managed care organizations
\n\u2022 CDC<\/td>\n<\/tr>\n
Payment for Administration<\/td>\n\u2022 Stakeholders may consider changes to facilitate multi-component billing for combination vaccines<\/td>\n\u2022 AMA, CPT Editorial Panel
\n\u2022 CMS
\n\u2022 Providers<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Download the white paper: Adult Seasonal Combination Respiratory Vaccines: Policy Considerations<\/a>.<\/p>\n

To learn more about the landscape for adult combination vaccines, connect with us<\/a>.<\/p>\n

Funding for this research was provided by Pfizer. Avalere retained full editorial control.<\/em><\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Combination vaccines can provide protection against and potentially prevent multiple diseases through a single vaccination. Multiple adult combination vaccines are emerging in development pipelines and are expected to launch in the next decade, including products that confer protection against several respiratory illnesses such as influenza, COVID-19, and respiratory syncytial virus (RSV). Stakeholders have noted the…<\/p>\n","protected":false},"author":28,"featured_media":26335,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"content-categories":[131],"class_list":["post-31967","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights","content-categories-vaccines","entry","has-media"],"acf":[],"yoast_head":"\nAdult Seasonal Combination Respiratory Vaccines: Policy Considerations | Avalere Health Advisory<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adult Seasonal Combination Respiratory Vaccines: Policy Considerations | Avalere Health Advisory\" \/>\n<meta property=\"og:description\" content=\"Combination vaccines can provide protection against and potentially prevent multiple diseases through a single vaccination. Multiple adult combination vaccines are emerging in development pipelines and are expected to launch in the next decade, including products that confer protection against several respiratory illnesses such as influenza, COVID-19, and respiratory syncytial virus (RSV). Stakeholders have noted the…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations\" \/>\n<meta property=\"og:site_name\" content=\"Avalere Health Advisory\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-06T13:30:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-06T19:46:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/06\/16275-1-Mitchell_Finkel_600x400-e1655932372341.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Leah Keller\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@avalerehealth\" \/>\n<meta name=\"twitter:site\" content=\"@avalerehealth\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Leah Keller\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adult Seasonal Combination Respiratory Vaccines: Policy Considerations | Avalere Health Advisory","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations","og_locale":"en_US","og_type":"article","og_title":"Adult Seasonal Combination Respiratory Vaccines: Policy Considerations | Avalere Health Advisory","og_description":"Combination vaccines can provide protection against and potentially prevent multiple diseases through a single vaccination. Multiple adult combination vaccines are emerging in development pipelines and are expected to launch in the next decade, including products that confer protection against several respiratory illnesses such as influenza, COVID-19, and respiratory syncytial virus (RSV). Stakeholders have noted the…","og_url":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations","og_site_name":"Avalere Health Advisory","article_published_time":"2024-05-06T13:30:14+00:00","article_modified_time":"2024-05-06T19:46:58+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/06\/16275-1-Mitchell_Finkel_600x400-e1655932372341.jpg","type":"image\/jpeg"}],"author":"Leah Keller","twitter_card":"summary_large_image","twitter_creator":"@avalerehealth","twitter_site":"@avalerehealth","twitter_misc":{"Written by":"Leah Keller","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#article","isPartOf":{"@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations"},"author":{"name":"Leah Keller","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/fb195190cdd6a0c7c2cc890515dd95f4"},"headline":"Adult Seasonal Combination Respiratory Vaccines: Policy Considerations","datePublished":"2024-05-06T13:30:14+00:00","dateModified":"2024-05-06T19:46:58+00:00","mainEntityOfPage":{"@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations"},"wordCount":454,"commentCount":0,"publisher":{"@id":"https:\/\/advisory.avalerehealth.com\/#organization"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#primaryimage"},"thumbnailUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/06\/16275-1-Mitchell_Finkel_600x400-e1655932372341.jpg","articleSection":["Insights & Analysis"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#respond"]}]},{"@type":"WebPage","@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations","url":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations","name":"Adult Seasonal Combination Respiratory Vaccines: Policy Considerations | Avalere Health Advisory","isPartOf":{"@id":"https:\/\/advisory.avalerehealth.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#primaryimage"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#primaryimage"},"thumbnailUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/06\/16275-1-Mitchell_Finkel_600x400-e1655932372341.jpg","datePublished":"2024-05-06T13:30:14+00:00","dateModified":"2024-05-06T19:46:58+00:00","breadcrumb":{"@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#primaryimage","url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/06\/16275-1-Mitchell_Finkel_600x400-e1655932372341.jpg","contentUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/06\/16275-1-Mitchell_Finkel_600x400-e1655932372341.jpg","width":600,"height":400,"caption":"Mitchell Finkel"},{"@type":"BreadcrumbList","@id":"https:\/\/advisory.avalerehealth.com\/insights\/adult-seasonal-combination-respiratory-vaccines-policy-considerations#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/advisory.avalerehealth.com\/"},{"@type":"ListItem","position":2,"name":"Adult Seasonal Combination Respiratory Vaccines: Policy Considerations"}]},{"@type":"WebSite","@id":"https:\/\/advisory.avalerehealth.com\/#website","url":"https:\/\/advisory.avalerehealth.com\/","name":"Avalere Health Advisory","description":"","publisher":{"@id":"https:\/\/advisory.avalerehealth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/advisory.avalerehealth.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/advisory.avalerehealth.com\/#organization","name":"Avalere Health","url":"https:\/\/advisory.avalerehealth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/logo\/image\/","url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2025\/03\/avalere-health-logo-cropped-white_1x.webp","contentUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2025\/03\/avalere-health-logo-cropped-white_1x.webp","width":433,"height":47,"caption":"Avalere Health"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/avalerehealth"]},{"@type":"Person","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/fb195190cdd6a0c7c2cc890515dd95f4","name":"Leah Keller","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4a87f9cf63da84fab5720429686278df?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4a87f9cf63da84fab5720429686278df?s=96&d=mm&r=g","caption":"Leah Keller"},"description":"Leah Keller co-manages and edits the Policy 360 Research Series sits on Avalere\u2019s Marketing Team. Prior to joining Avalere, Leah conducted policy research and analysis on federal healthcare issues such as Medicaid coverage and payment, commercial insurance coverage and access, healthcare reform, and ACA implementation at the Guttmacher Institute, a thinktank focused on advancing reproductive health and rights. Prior, Leah coordinated data collection, analysis, and publications for George Washington University\u2019s Center for Social Well-Being and Development. Leah holds an MPH in maternal and child health from George Washington University and a BA in anthropology from St. Mary\u2019s College of Maryland.","url":"https:\/\/advisory.avalerehealth.com\/author\/lkelleravalere-com"}]}},"_links":{"self":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/31967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/comments?post=31967"}],"version-history":[{"count":19,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/31967\/revisions"}],"predecessor-version":[{"id":32034,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/31967\/revisions\/32034"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/media\/26335"}],"wp:attachment":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/media?parent=31967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/categories?post=31967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/tags?post=31967"},{"taxonomy":"content-categories","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/content-categories?post=31967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}